GoHealth Inc.’s 2nd Quarter 2021 LTV and Approved Policy results
Telos Actuarial recently compiled key information on GoHealth Inc.’s (NASDAQ: GOCO) 2nd Quarter Financial results.
One of the key metrics reported by GoHealth on a quarterly basis is constrained Lifetime Value (“LTV”) per approved policy. LTV is the estimated amount of commissions the company expects to receive over the life of the policy, per approved policy.
*Estimated based on year-end results
GoHealth’s LTV increased for their Medicare Advantage (“MA”) line, decreased for Medicare Supplement (“MS”), and remained level for Prescription Drug Plans (“PDP”) when compared to the same quarter last year.
GoHealth’s commentary on LTV mentions some of the reasons for the changes in LTV. They mention that the increase in Medicare Advantage LTV “was primarily due to an increase in commission rates”, while the decrease for Medicare Supplement LTV “was primarily due to changes in carrier mix.”
Another key metric reported by GoHealth is approved policy counts (for commissionable policies). Overall approved policy counts increased 55% when compared to the same quarter last year.
Growth in approved policy counts continues to be driven by Medicare Advantage.
Source data: GoHealth Inc.’s quarterly Form 10-Q (https://investors.gohealth.com/financial-information/quarterly-results)
Telos Actuarial helps distributors maximize the lifetime value (“LTV”) of their commissions by providing persistency analysis, industry lapse and persistency reports, projected commission cash flow analysis, and LTV calculations. Send us an email for more information. info@telosactuarial.com
